ANNX
NASDAQ · Biotechnology
Annexon Inc
$5.69
+0.17 (+3.08%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+617.2% upside
Low Target
$23.52
Average Target
$40.81
High Target
$51.70
Current Price
$5.69
Current
$5.69
$5.69
Target
$40.81
$40.81
$23.52
$40.81 avg
$51.70
Scenario Analysis
Bear Case
$23.52
313.4%
Low target
Base Case
$40.81
+617.2%
Avg target
Bull Case
$51.70
+808.6%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$7.18
-20.8% from high
52-Week Low
$1.60
+255.6% from low
Target vs 52W High
$40.81
+468.4% vs high
Next Earnings Report
May 18, 2026
7d
until earnings
EPS Est: $-0.29
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |